Page 95 - JCBP-2-3
P. 95

Journal of Clinical and
            Basic Psychosomatics                                                Psychological changes in patient with ICD



               2010;7(4):549-558.                              11.  Pedersen SS, Nielsen JC, Wehberg S, et al. New onset anxiety
               doi: 10.1016/j.hrthm.2009.12.006                   and depression in patients with an implantable cardioverter
                                                                  defibrillator during 24 months of follow-up (data from the
            3.   Krahn AD, Tfelt-Hansen J, Tadros R, Steinberg C,   national DEFIB-WOMEN study). Gen Hosp Psychiatry.
               Semsarian  C, Han HC. Latent causes of sudden cardiac   2021;72:59-65.
               arrest. JACC Clin Electrophysiol. 2022;8(6):806-821.
                                                                  doi: 10.1093/europace/euab116.424.
               doi: 10.1016/j.jacep.2021.12.014
                                                               12.  Dubovsky SL, Marshall D. Benzodiazepines remain
            4.   Habibović M, Pedersen SS, Broers ER, et al. Prevalence of   important therapeutic options in psychiatric practice.
               anxiety and risk associated with ventricular arrhythmia in   Psychother Psychosom. 2022;91(5):307-334.
               patients with an implantable cardioverter defibrillator. Int J
               Cardiol. 2020;310:80-85.                           doi: 10.1159/000524400
               doi: 10.1016/j.ijcard.2020.02.005               13.  Kahl KG, Stapel B, Correll CU. Psychological and
                                                                  psychopharmacological interventions in psychocardiology.
            5.   Lindekilde N, Skov O, Skovbakke SJ, Johansen JB,
               NielsencJC, Pedersen SS. Anxiety and depression as risk   Front Psychiatry. 2022;13:831359.
               factors for ICD shocks and mortality in patients with an      doi: 10.3389/FPSYT.2022.831359
               implantable  cardioverter  defibrillator-a systematic  review.   14.  Wu CS, Tsai YT, Hsiung CA, Tsai HJ. Comparative risk of
               Gen Hosp Psychiatry. 2022;78:96-107.
                                                                  ventricular arrhythmia and sudden cardiac death across
               doi: 10.1016/j.genhosppsych.2022.07.008            antidepressants in patients with depressive disorders. J Clin
            6.   Priori  SG,  Wilde  AA,  Horie  M,  et al.  HRS/EHRA/  Psychopharmacol. 2017;37(1):32-39.
               APHRS expert consensus statement on the diagnosis and      doi: 10.1097/JCP.0000000000000631
               management of patients with inherited primary arrhythmia
               syndromes: Document endorsed by HRS, EHRA, and   15.  Leppert F, Siebermair J, Wesemann U. The influence of
               APHRS in May 2013 and by ACCF, AHA, PACES, and     remote  monitoring  on anxiety/depression,  quality  of life,
               AEPC in June 2013. Heart Rhythm. 2013;10(12):1932-1963.  and device acceptance in ICD patients: A  prospective,
                                                                  randomized, controlled, single-center trial. Clin Res Cardiol.
               doi: 10.1093/europace/eut272.                      2021;110(6):789-800.
            7.   Wong MF. Factors associated with anxiety and depression      doi: 10.1007/s00392-020-01667-0
               among patients with implantable cardioverter defibrillator.
               J Clin Nurs. 2017;26(9-10):1328-1337.           16.  Berg SK, Rasmussen TB, Herning M,  et al. Cognitive
                                                                  behavioural therapy significantly reduces anxiety in patients
               doi: 10.1111/jocn.13637
                                                                  with implanted cardioverter defibrillator compared with
            8.   Ghezzi ES, Sharman RL, Selvanayagam JB, et al. Burden of   usual care: Findings from the Screen-ICD randomised
               mood symptoms and disorders in implantable cardioverter   controlled trial. Eur J Prev Cardiol. 2020;27(3):258-268.
               defibrillator patients: A systematic review and meta-analysis
               of 39 954 patients. Europace. 2023;25(6):euad130.     doi: 10.1177/2047487319874147.
               doi: 10.1093/europace/euad130                   17.  Aditee D, Pankaj M, Neil B,  et al. Meditation for
                                                                  improved clinical outcomes in patients with implantable
            9.   Perini AP, Kutyifa V, Veazie P, et al. Effects of implantable   defibrillators for heart failure-pilot study. J Atr Fibrillation.
               cardioverter/defibrillator shock and antitachycardia pacing   2020;12(6):2314.
               on anxiety and quality of life: A MADIT-RIT substudy. Am
               Heart J. 2017;189:75-84.                           doi: 10.4022/jafib.2314
               doi: 10.1016/j.ahj.2017.03.009                  18.  Saeed SA, Cunningham K, Bloch RM.  Depression and
                                                                  anxiety disorders: Benefits of exercise, yoga, and meditation.
            10.  Fumagalli S, Pieragnoli P, Haugaa KH, et al. The influence   Am Fam Physician. 2019;99(10):620-627.
               of age on the psychological profile of patients with cardiac
               implantable  electronic devices:  Results  from the  Italian   19.  Dougherty CM, Burr RL, Kudenchuk PJ, Glenny RW.
               population in a multicenter study conducted by the   Aerobic exercise effects on quality of life and psychological
               European heart rhythm association. Aging Clin Exp Res.   distress  after  an  implantable  cardioverter  defibrillator.
               2019;31(9):1219-1226.                              J Cardiopulm Rehabil Prev. 2020;40(2):94-101.
               doi: 10.1007/s40520-018-1088-5                     doi: 10.1097/HCR.0000000000000444









            Volume 2 Issue 3 (2024)                         7                               doi: 10.36922/jcbp.2848
   90   91   92   93   94   95   96   97   98